Copanlisib in Combination with Rituximab and Bendamustine for Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: Results from the Phase II Multicenter Fil_Copa-Rb Trial from Fondazione Italiana Linfomi (FIL)Pio Manlio Mirko Frascione,Mattia Novo,Alessia Castellino,Luigi Marcheselli, Samantha Deianira Dattoli,Alessandra Tucci,Guido Gini,Giuseppe Tarantini,Donato Mannina,Annalisa Arcari, Roberta Martiniani, Elisabetta Scarpa,Dario Marino,Michele Spina, Ausilia Giuseppa Gorgone,Nicola Di Renzo,Salvatrice Mancuso,Luigi Petrucci,Agostino Tafuri,Umberto VitoloBLOOD（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
